Intensity Therapeutics
(NASDAQ:INTS)
$3.6145
-0.1955[-5.13%]
At close: Apr 18
$3.6145
0[0.00%]
After Hours: 5:44PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Intensity Therapeutics Stock (NASDAQ:INTS), Quotes and News Summary

Intensity Therapeutics Stock (NASDAQ: INTS) stock price, news, charts, stock research, profile.

Open$3.820
Close$3.880
Volume / Avg.5.135K / 56.824K
Day Range3.800 - 3.950
52 Wk Range2.010 - 11.440
Market Cap$49.553M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
35
Short Interest
0.3%
Days to Cover1.16

Recent News

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.
Avi Kapoor
Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining investment in Lynx Motors. Nxu, shares rose 42.1% to $0.0278 in pre-market trading. Here are some other stocks moving in pre-market trading.
Avi Kapoor
Dow Jumps Over 100 Points; MBIA Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Friday. The Dow traded up 0.36% to 36,248.73 while the NASDAQ rose 0.48% to 14,409.22. The S&P 500 also rose, gaining, 0.42% to 4,604.73.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
0
0
0
0
Nov 23
0
0
0
0
Mar
Buy
Hold
Sell
Strong Sell
About Intensity Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based a...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
INTS
KZR

FAQ

Q

How do I buy Intensity Therapeutics (INTS) stock?

A

You can purchase shares of Intensity Therapeutics (NASDAQ: INTS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intensity Therapeutics's (INTS) competitors?

A

Other companies in Intensity Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Vaxxinity (NASDAQ:VAXX), Gain Therapeutics (NASDAQ:GANX), Eagle Pharmaceuticals (NASDAQ:EGRX) and Immuneering (NASDAQ:IMRX).

Q

What is the target price for Intensity Therapeutics (INTS) stock?

A

The latest price target for Intensity Therapeutics (NASDAQ: INTS) was reported by Benchmark on Thursday, March 21, 2024. The analyst firm set a price target for 12.00 expecting INTS to rise to within 12 months (a possible 232.00% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intensity Therapeutics (INTS)?

A

The stock price for Intensity Therapeutics (NASDAQ: INTS) is $3.6145 last updated April 18, 2024 at 5:44 PM EDT.

Q

Does Intensity Therapeutics (INTS) pay a dividend?

A

There are no upcoming dividends for Intensity Therapeutics.

Q

When is Intensity Therapeutics (NASDAQ:INTS) reporting earnings?

A

Intensity Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.

Q

Is Intensity Therapeutics (INTS) going to split?

A

There is no upcoming split for Intensity Therapeutics.

Q

What sector and industry does Intensity Therapeutics (INTS) operate in?

A

Intensity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch